Citrine Medicine
Latest round
- Series A
Last raised
- Jul 2020
Total raised
- $80M
Investors
- 4
About Citrine Medicine
Founded in 2019 and based in Shanghai, China, Citrine Medicine operates as a pharmaceutical company that focuses on the development and production of rare disease drugs. It has 2 branch offices, which are Citrine Medicine and Zircon Health. Citrine Medicine's main business is the development and commercialization of drugs for rare diseases. Its business can be categorized into pharmaceuticals and medical services. It has 8 rare disease drugs currently in the product pipeline, such as Wakix, Imcivree, and Efmody. Products can be used in the treatment of neuroscience, endocrine, and metabolic diseases. The company also provides services such as rare disease intelligence consultation, information inquiry, and knowledge dissemination. The company generates revenue by providing rare disease drugs.
Who invested in Citrine Medicine
4 investors across 1 round
See all investors in Citrine Medicine
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Jul 14, 2020
Amount
$80M
Investors
Questions about Citrine Medicine
Who invested in Citrine Medicine?
Citrine Medicine has 4 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Citrine Medicine raised?
Citrine Medicine has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Citrine Medicine last raise money?
Citrine Medicine's most recent round on record is a Series A, in Jul 2020.
What does Citrine Medicine do?
Founded in 2019 and based in Shanghai, China, Citrine Medicine operates as a pharmaceutical company that focuses on the development and production of rare disease drugs.
Where is Citrine Medicine headquartered?
Citrine Medicine is headquartered in Shanghai, China.
Which VCs invest in companies like Citrine Medicine?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back pharmaceuticals companies at Citrine Medicine's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series A
Raising like Citrine Medicine? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.